Pular para o conteúdo
Merck
Todas as fotos(2)

Documentos Principais

Visualizar Toda a Documentação

59353-U

Supelco

Discovery® C8 (5 µm) HPLC Columns

L × I.D. 15 cm × 4.6 mm, HPLC Column

Sinônimo(s):

C8 Reversed-Phase Chromatography Column

Faça loginpara ver os preços organizacionais e de contrato
Todas as fotos(2)

About This Item

Código UNSPSC:
41115700
eCl@ss:
32110501
NACRES:
SB.52

Nome do produto

Discovery® C8 HPLC Column, 5 μm particle size, L × I.D. 15 cm × 4.6 mm

Materiais

stainless steel column

Nível de qualidade

100

Agency

suitable for USP L7

linha de produto

Discovery®

Características

endcapped

fabricante/nome comercial

Discovery®

embalagem

1 ea of

Extensão da rotulagem

7.5% Carbon loading

Parâmetros

≤70 °C temp. range
400 bar pressure (5801 psi)

técnica(s)

HPLC: suitable
LC/MS: suitable

C × D.I.

15 cm × 4.6 mm

área da superfície

200 m2/g

cobertura de superfície

3.4 μmol/m2

Impurezas

<10 ppm metals

Matriz

silica gel, high purity, spherical base material
fully porous particle

Grupo ativo da matriz

C8 (octyl) phase

tamanho de partícula

5 μm

tamanho de poro

180 Å

Faixa de pH operacional

2-8

aplicação(ões)

food and beverages

técnica de separação

reversed phase

Procurando produtos similares? Visita Guia de comparação de produtos

Categorias relacionadas

Aplicação

Discovery® C8 HPLC column has been used in the separation of fluoroquinolone antibiotics in tablets using reversed-phase high-performance liquid chromatography (RP-HPLC).

Características e benefícios

  • Excellent reproducibility
  • Faster separation of strongly hydrophobic analytes than C18 columns
  • Stable, low-bleed LC-MS separations
  • Exceptional peak shapes for basic and acidic compounds
  • Compatible with low organic/highly aqueous mobile phases

Informações legais

Discovery is a registered trademark of Merck KGaA, Darmstadt, Germany

Escolha uma das versões mais recentes:

Certificados de análise (COA)

Lot/Batch Number
281287-06
281287-05
281287-04
281287-03
281287-02

Não está vendo a versão correta?

Se precisar de uma versão específica, você pode procurar um certificado específico pelo número do lote ou da remessa.

Pesquise por COA

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

Os clientes também visualizaram

Slide 1 of 7

1 of 7

Coluna de HPLC LC-8-DB SUPELCOSIL&#8482; 5&#160;&#956;m particle size, L × I.D. 15&#160;cm × 4.6&#160;mm

Supelco

58347

Coluna de HPLC LC-8-DB SUPELCOSIL™

Coluna de HPLC LC-18 SUPELCOSIL&#8482; 5&#160;&#956;m particle size, L × I.D. 15&#160;cm × 4.6&#160;mm

Supelco

58230-U

Coluna de HPLC LC-18 SUPELCOSIL™

Fosfatase alcalina (FA) grade I, from calf intestine

Roche

API-RO

Fosfatase alcalina (FA)

Sodium formate ACS reagent, &#8805;99.0%

Sigma-Aldrich

247596

Sodium formate

Ascentis&#174; C18 HPLC Column 5&#160;&#956;m particle size, L × I.D. 25&#160;cm × 4.6&#160;mm

Supelco

581325-U

Ascentis® C18 HPLC Column

m-Cresol 99%

Sigma-Aldrich

C85727

m-Cresol

tert-Butylamine &#8805;99.5%

Sigma-Aldrich

391433

tert-Butylamine

Scott C Bell et al.
Pharmacology & therapeutics, 145, 19-34 (2014-06-17)
With the discovery of the CFTR gene in 1989, the search for therapies to improve the basic defects of cystic fibrosis (CF) commenced. Pharmacological manipulation provides the opportunity to enhance CF transmembrane conductance regulator (CFTR) protein synthesis and/or function. CFTR
Bo-Rui Kang et al.
Bioorganic & medicinal chemistry letters, 25(24), 5808-5812 (2015-11-08)
2-Benzylisoquinolin-1(2H)-ones has been proposed as vasodilative agents on the basis of scaffold hopping. In the present study, a series of 2-benzylisoquinolin-1(2H)-ones were synthesized. Their vasodilative effects were evaluated by wire myograph on isolated rat mesenteric arterial ring induced contraction with
Hugo M Botelho et al.
Scientific reports, 5, 9038-9038 (2015-03-13)
Plasma membrane proteins are essential molecules in the cell which mediate interactions with the exterior milieu, thus representing key drug targets for present pharma. Not surprisingly, protein traffic disorders include a large range of diseases sharing the common mechanism of
M Q Zhang et al.
Die Pharmazie, 46(10), 687-700 (1991-10-01)
The rapid growth in the quinolone research changed the whole face of the previous SAR concepts. So far structural modifications at all positions of the quinolone nucleus except the 4-oxo group have successfully lead to the discovery of potent antimicrobial
G L Bundy et al.
The Journal of biological chemistry, 261(2), 747-751 (1986-01-15)
The gorgonian coral Pseudoplexaura porosa contains a lipoxygenase capable of converting exogenous arachidonic acid into (8R)-8-hydroperoxy-5,9,11,14-eicosatetraenoic acid. The (8R)- (or 8-L-) configuration in this product, opposite to that observed in previously reported 8-lipoxygenase products, was determined unambiguously by comparison of
Exibir todos os documentos relacionados

Conteúdo relacionado

Discovery C18 and C8 HPLC Columns

Discovery C18 and C8 HPLC Columns products offered

Global Trade Item Number

SKUGTIN
59353-U4061838550194

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica